VivoSim Labs (VIVS) Change in Receivables (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Change in Receivables of -$1000.0 for Q1 2026, down 125.0% year-over-year from $4000.0 in Q1 2025, and down 200.0% quarter-over-quarter from $1000.0 in Q4 2025.
VivoSim Labs (VIVS) Change in Receivables (2011 - 2026) Analysis & Trends
VivoSim Labs' Change in Receivables history runs 13 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 125.0% year-over-year to -$1000.0; the TTM figure through Mar 2026 stood at $2000.0 (up 166.67% YoY), while the FY2026 annual figure was $2000.0, up 166.67% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1000.0, down from $1000.0 in the prior quarter.
- The five-year high for Change in Receivables was $76000.0 in Q4 2022, with the low at -$94000.0 in Q3 2023.
- The 5-year median for Change in Receivables is $0.0 (2025), against an average of $2666.7.
- The sharpest annual moves came in 2023 and 2024: Change in Receivables plunged 128.95% in 2023, then jumped 600.0% in 2024.
- VivoSim Labs' Change in Receivables stood at $76000.0 in 2022, then plunged by 128.95% to -$22000.0 in 2023, then jumped by 86.36% to -$3000.0 in 2024, then soared by 133.33% to $1000.0 in 2025, then slumped by 200.0% to -$1000.0 in 2026.
- Business Quant data shows VIVS's Change in Receivables at -$1000.0 in Q1 2026, $1000.0 in Q4 2025, and $2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,000.00 |
| Jun 30, 2026 | -3,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Dec 31, 2024 | -3,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Sep 30, 2024 | -19,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | -94,000.00 |
| Sep 30, 2023 | -94,000.00 |